← Back to Search

Cannabinoid

Cannabis for Cannabis

Phase 2
Waitlist Available
Research Sponsored by New York State Psychiatric Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Current cannabis user
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 15 days
Awards & highlights

Study Summary

This trial will assess if repeated cannabis use can result in hyperalgesia and if tolerance to the analgesic and abuse-related effects of cannabis develops and is reversible.

Eligible Conditions
  • Cannabis
  • Pain
  • Drug Tolerance
  • Hyperalgesia

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are using cannabis currently.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 15 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 15 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Cold Pressor Test (CPT) latency
Secondary outcome measures
Change in Cannabis Rating Form (CRF) ratings
Change in Quantitative Sensory Testing-Thermal Temporal Summation (QST-TTS) ratings

Trial Design

1Treatment groups
Experimental Treatment
Group I: Dose A, followed by Dose BExperimental Treatment1 Intervention
On the first full inpatient day (Day 1), participants will smoke one specified strength (Dose A) of cannabis. Days 2-8 will comprise Phase 1, in which a second strength (Dose B) of cannabis will be administered 3x/day. The next 7 days (Day 9-15) will be Phase 2, in which cannabis Dose A will be administered once again, at the same 3 daily time points.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cannabis
2014
Completed Phase 3
~810

Find a Location

Who is running the clinical trial?

Alkermes, Inc.Industry Sponsor
113 Previous Clinical Trials
26,720 Total Patients Enrolled
New York State Psychiatric InstituteLead Sponsor
474 Previous Clinical Trials
153,241 Total Patients Enrolled
4 Trials studying Cannabis
160 Patients Enrolled for Cannabis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the unique aspects of this research?

"As of right now, there are 35 ongoing studies involving Cannabis being conducted in 5 different countries and across 35 cities. The first such study was completed in 2015 by Jazz Pharmaceuticals. That trial involved 200 participants and reached its Phase 2 & 3 drug approval stage. Since then, 61 more trials have been conducted."

Answered by AI

Is there a potential for long-term adverse effects from using Cannabis?

"While there is some evidence that cannabis is safe, as this is only a Phase 2 trial, it received a score of 2."

Answered by AI

Could you direct me to other research that has been conducted on Cannabis?

"Currently, there are 35 Clinical Trials underway for Cannabis. 3 of these trials have reached Phase 3. These medical studies are being conducted in various places across the world, with a significant concentration in Hartford, Connecticut."

Answered by AI

How many people have been asked to take part in this research project?

"Yes, an analysis of the clinicaltrials.gov website reveals that this study is still looking for 16 additional patients from 1 centre. The listing was first posted on June 1st, 2021 and was last updated 17 days ago on June 17th, 2022."

Answered by AI

How do I sign up for this experiment?

"This study requires 16 participants that currently use cannabis and experience pain, falling in the age range of 21 to 60. It is also important to note that all patients must be male or non-pregnant females."

Answered by AI

Are volunteers currently being enrolled in this experiment?

"The trial is currently ongoing, as seen on clinicaltrials.gov. The posting dates for this study are from June 1st 2021 to June 17th 2022. They are recruiting 16 patients at a single location."

Answered by AI

Will this experiment be testing individuals who are over 45 years old?

"Eligibility for this trial is restricted to patients that fall between the ages of 21 and 60. In contrast, 102 trials are available for minors and 347 exist for senior citizens."

Answered by AI

Who else is applying?

What state do they live in?
Connecticut
Other
New Jersey
New York
How old are they?
18 - 65
What site did they apply to?
New York State Psychiatric Institute
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
1
3+
0

Why did patients apply to this trial?

~4 spots leftby Mar 2025